[1]
“Features of inflammatory and cytolytic syndromes and their influence on the development of cardiomyofibrosis in patients with myocarditis with heart failure”, АПММ, no. 11, pp. 37–47, Jun. 2023, doi: 10.26565/2617-409X-2023-11-05.